发明名称 СПОСОБ ДИАГНОСТИКИ СИНДРОМА СИСТЕМНОЙ ВОСПАЛИТЕЛЬНОЙ РЕАКЦИИ ПО ОСНОВНЫМ СИСТЕМАМ ЖИЗНЕОБЕСПЕЧЕНИЯ
摘要 FIELD: medicine. ^ SUBSTANCE: method involves determining system injury labels A, where A=0 corresponds to no potentially dangerous injury being recognized; A=1 to availability of marked alteration with injury markers generalization like incompatible group blood transfusion, heavy traumas with hemorrhage with more than 1 l of blood lost, or visceral organ injury, burns of 3-4th severity degree with more than 10% of body surface area, heavy poisonings, sharp pyoinflammatory diseases satisfying to 2-4 SIRS criteria, development of anaphylactic system response; A=2 corresponds to availability of injuries being classified as critical conditions risk factor; intensity inflammatory system response manifestations B, where =1 corresponds to availability of D-dimers in concentration greater than 3 mcg/ml or fibrin-monomer complexes or > 20 mcg/ml; availability of early stage organ microcirculation injury labels C, where C=1 corresponds to myoglobin level greater than 60 ng/ml with no signs of marked muscle tissue injury or greater than 800 ng/ml without injury conditions, or troponin level I- 0.2-1.0 ng/ml or greater than 1 ml when excluding primary myocardial infarction. Organ dysfunction is estimated in SOFA scale. Critical condition is evaluated as D where D=1 corresponds to 2-5 points of SOFA scale; D=2 corresponds to critical condition statement in the following cases. 1) 6-24 SOFA points, 2) 2-5 SOFA points with clinical multiple organ failure/dysfunction symptoms being available, 3) shock or decompensated disseminated intravascular coagulation syndrome phase availability. Emergency state development risk factors are determined, where F=1 shows to additional risk factors availability like age >60 years, immune deficiency states, diabetes mellitus, chronic cardiac or pulmonary insufficiency availability in anamnesis. A=1 and B=1 being found to take place, inflammatory system response syndrome is diagnosed. The case of A=1 and B=1 (with C=1 or D=1 and F=1 as well), or A=2, emergency state development risk caused by inflammatory system response syndrome is to be predicted. D=2 and/or A=2 being the case, emergency state is diagnosed. ^ EFFECT: high accuracy in estimating inflammatory system response syndrome development risk. ^ 3 tbl
申请公布号 RU2005108805(A) 申请公布日期 2006.09.10
申请号 RU20050108805 申请日期 2005.03.28
申请人 Институт иммунологии и физиологии Уральского отделени  Российской Академии наук (ИИФ УрО РАН) (RU) 发明人 Гусев Евгений Юрьевич (RU);Черешнев Валерий Александрович (RU);Юрченко Любовь Николаевна (RU)
分类号 A61B10/00 主分类号 A61B10/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利